TWL said the company backed the highest ever wagon order placed in the history of Indian Railways for a basic value of about INR7800 crore and a total value of INR9000 crore plus, taking the order backlog to INR10,00 crore for the Indian operation.
Q&A Insights: Abhijeet Dey of Equentis enquired about the avg. blended margins over 3 years for the Indian Railways order. Umesh Chowdhary MD said that avg. blended margin at EBITDA level in TWL’s business is 8-10%. And with the Indian Railways order, it expects the same guidance
Q&A Insights: Subhankar Ojha from @SKScapital asked about the bidding order pipeline. Umesh Chowdhary MD answered that the comapny has a healthy tender pipeline. And also added that demand for metro coaches remain healthy in India.
Q&A Insights: Subhankar Ojha of @SKScapital asked about ROCE generated from overseas operations and potential earnings for next 2-3 years. Umesh C MD said the order book is of EUR500 million. And in 2022-23, expects to be EBITDA positive, while in 2023-24, to be net positive.
Q&A Insights: Vasudev with @EdelweissFin enquired about delivery terms of Indian Railways order and the split between FY23, FY24 and beyond. Umesh Chowdhary MD replied that the order is to be delivered over 39 months; 25-30% in the first year and the balance in next two years.
Q&A Insights: Vasudev with @EdelweissFin asked about Pune's contract status and the full execution timeframe. Umesh Chowdhary MD answered that barring the COVID delays etc. TWL is on track and added that by FY23, the contract is expected to be fully executed.
Q&A Insights: Vasudev with @EdelweissFin clarified about FY22 capex. Umesh Chowdhary MD said it is close to INR100 crores, primarily funded out of internal accruals.
Q&A Insights: Sreeram Ramdas of @Greenportfolioc enquired if TWL has the capacity to execute all its current orders over next 3-4 years. Umesh Chowdhary MD clarified that by and large the company has the capacity. If any balancing capacity needs to be created, it will be created.
To read further on the detailed analysis of #TWL#Q4 concall Q&A …
Q&A Insights: Nitin Gandhi of @KifsTrade asked about reason for volatility in EBITDA margin. Udit S Director said it's because of demand supply imbalance due to COVID for last couple of qtrs. The volatility is expected to continue for a while, though a bit of moderation is seen.
Q&A Insights: Nitin Gandhi of @KifsTrade also asked about nature of huge loans extended in 2022. Udit Sethia Director said that these are loans given by INTLCONV under the respective approvals and are given under market ICD rate, which will give market rate return to the company.
Q&A Insights: Vivek Subbaraman of Ambit Capital asked if company's current balance sheet allows it to bid for IPL at all. Punit Goenka MD replied that it does and ZEEL can participate on its own. ZEEL has zero debt and has qualification to participate in the tender.
Q&A Insights: Vivek Subbaraman of Ambit Capital also enquired if ZEEL is contemplating taking on debt to bid for IPL rights. Punit Goenka MD said it's currently studying all options. There is no need to pay a large sum upfront. Only when the rights start, it will have to pay.
Q&A Insights: Harsh Shah of @lntmutualfund asked about full year revenue growth breakdown in terms of volume and value. Pratik Bora CFO said most of the growth came from volume. For BHA, the most margin-accretive product in portfolio, witnessed around 50% volume growth.
Q&A Insights: Harsh Shah of @lntmutualfund enquired about overall client additions. Siddharth Sikchi ED said it first added 2 new products; para benzoquinone and TBHQ. In products like BHA, added some new customers in LatAm.
Q&A Insights: Gagan Thareja of @ASK_WM asked if growth would get constrained due to lack of capacity for first 3 qtrs of FY23. Rohan D Director said it is currently at 80% utilization and is constantly debottlenecking plants to increase capacity. Expects to reach 90-92% in FY23.
Q&A Insights: Gagan Thareja of @ASK_WM enquired about breakdown of sales growth into volume growth and price of sales mix for FY22. Rohan Desai Director replied that price increased by only 1.5-2% on an avg. overall, therefore whole growth in FY22 was due to volume.
Despite two COVID waves, AFL grew revenues 32%, and reduced net debt by more than INR525 crores in the year. Expects retail and online channels to continue to drive growth and account for 60% to 65% of overall sales.
Q&A Insights: Nishit Rathi of CWC asked if US Polo, Tommy, Arrow, and Flying Machine, those will reach double-digit. Shailesh Chaturvedi MD said AFL’s guidance is that it should hit total portfolio double-digit pre-IndAS EBITDA in 12 to 18 months.
Q&A Insights: Gaurav Jogani with @AXIS_Capital asked if the company took any price increase beyond the price increase announced in Dec. VS Ganesh CEO replied that the company didn’t have any further price increase other than the one it had in Dec.
Q&A Insights: Gaurav J of @AXIS_Capital asked that given the raw material stock PAGEIND has, if further price increase will be needed given the higher cotton prices. VS Ganesh CEO said it is closely monitoring the situation. If there is a need, PAGEIND will be touching the prices